ATE271861T1 - Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen - Google Patents
Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungenInfo
- Publication number
- ATE271861T1 ATE271861T1 AT99925537T AT99925537T ATE271861T1 AT E271861 T1 ATE271861 T1 AT E271861T1 AT 99925537 T AT99925537 T AT 99925537T AT 99925537 T AT99925537 T AT 99925537T AT E271861 T1 ATE271861 T1 AT E271861T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonists
- treatment
- inflammatory diseases
- sodium channel
- nmda
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9801494A SE9801494D0 (sv) | 1998-04-28 | 1998-04-28 | Novel use |
PCT/SE1999/000701 WO1999055322A1 (en) | 1998-04-28 | 1999-04-28 | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE271861T1 true ATE271861T1 (de) | 2004-08-15 |
Family
ID=20411120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99925537T ATE271861T1 (de) | 1998-04-28 | 1999-04-28 | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen |
Country Status (8)
Country | Link |
---|---|
US (1) | US6221887B1 (de) |
EP (1) | EP1073430B1 (de) |
JP (1) | JP2002512955A (de) |
AT (1) | ATE271861T1 (de) |
AU (1) | AU4179399A (de) |
DE (1) | DE69918972T2 (de) |
SE (1) | SE9801494D0 (de) |
WO (1) | WO1999055322A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003081872A (ja) * | 2001-09-13 | 2003-03-19 | Nippon Oruganon Kk | 掻痒治療薬 |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US6702997B2 (en) | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030140920A1 (en) * | 2001-10-26 | 2003-07-31 | Dey L.P. | Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
GB0221956D0 (en) * | 2002-09-20 | 2002-10-30 | Novartis Ag | Organic compounds |
DE602004025586D1 (de) * | 2003-08-25 | 2010-04-01 | Newron Pharm Spa | Alpha-aminoamid derivate zur verwendung als anti-inflammatorische wirkstoffe |
ES2347581T3 (es) * | 2004-09-10 | 2010-11-02 | Newron Pharmaceuticals S.P.A. | Uso de (r)-(halobenciloxi)bencilamino-propanamidas como moduladores selectivos del canal de sodio y/o calcio. |
AU2006329040C1 (en) | 2005-12-22 | 2011-12-08 | Newron Pharmaceuticals S.P.A. | 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators |
TWI432188B (zh) * | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類 |
RU2484813C2 (ru) | 2008-12-19 | 2013-06-20 | Мерц Фарма Гмбх Унд Ко. Кгаа | Производные 1-амино-алкилциклогексана для лечения заболеваний, опосредованных тучными клетками |
WO2019190822A1 (en) | 2018-03-28 | 2019-10-03 | Vtv Therapeutics Llc | Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine |
WO2019190823A1 (en) | 2018-03-28 | 2019-10-03 | Vtv Therapeutics Llc | Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine |
JP7464591B2 (ja) | 2018-10-10 | 2024-04-09 | ブイティーブイ・セラピューティクス・エルエルシー | [3-(4-{2-ブチル-1-[4-(4-クロロ-フェノキシ)-フェニル]-1h-イミダゾール-4-イル}-フェノキシ)-プロピル]-ジエチル-アミンの代謝産物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538993A (en) * | 1991-09-12 | 1996-07-23 | Yissum Research Development Company | Certain tetrahydrocannabinol-7-oic acid derivatives |
US5635530A (en) | 1991-09-12 | 1997-06-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them |
ZA932761B (en) * | 1992-04-28 | 1993-10-28 | Battelle Memorial Institute | Diamine derivatives and application thereof in therapeutic fields |
CA2115792C (en) * | 1993-03-05 | 2005-11-01 | David J. Mayer | Method for the treatment of pain |
AUPN605795A0 (en) | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
-
1998
- 1998-04-28 SE SE9801494A patent/SE9801494D0/xx unknown
-
1999
- 1999-04-28 AU AU41793/99A patent/AU4179399A/en not_active Abandoned
- 1999-04-28 US US09/380,988 patent/US6221887B1/en not_active Expired - Fee Related
- 1999-04-28 DE DE69918972T patent/DE69918972T2/de not_active Expired - Fee Related
- 1999-04-28 AT AT99925537T patent/ATE271861T1/de not_active IP Right Cessation
- 1999-04-28 JP JP2000545521A patent/JP2002512955A/ja active Pending
- 1999-04-28 EP EP99925537A patent/EP1073430B1/de not_active Expired - Lifetime
- 1999-04-28 WO PCT/SE1999/000701 patent/WO1999055322A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE69918972D1 (de) | 2004-09-02 |
EP1073430B1 (de) | 2004-07-28 |
AU4179399A (en) | 1999-11-16 |
DE69918972T2 (de) | 2005-07-28 |
US6221887B1 (en) | 2001-04-24 |
EP1073430A1 (de) | 2001-02-07 |
SE9801494D0 (sv) | 1998-04-28 |
JP2002512955A (ja) | 2002-05-08 |
WO1999055322A1 (en) | 1999-11-04 |
WO1999055322A9 (en) | 2000-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
DE69838070D1 (de) | Substituierte pyridin-derivate als entzündungshemmende mittel | |
ATE179610T1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
NO20030845D0 (no) | Utvalgte fusjonerte pyrrolokarbazoler | |
DE69625691T2 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
NO20032254L (no) | Forbindelser for inhibering av ekspresjon av VACM-I | |
DE60118003D1 (de) | Harnstoffderivate und ihre verwendung | |
ATE417602T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
ATE235481T1 (de) | Substituierte benzopyranderivate zur behandlung von entzündungen | |
EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
ATE273690T1 (de) | Zusammensetzung zur hautdesinfizierung | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
ATE469907T1 (de) | Triptolid-analoga zur behandlung von autoimmunkranheiten und entzündungen | |
ATE422201T1 (de) | 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
DE59900286D1 (de) | Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten | |
ATE330938T1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |